Cargando…

Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis

BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Aaron Shengting, Lim, Oliver Zi Hern, Ho, Yeung Jek, Kong, Gwyneth, Lim, Grace En Hui, Ng, Cheng Han, Ho, Cyrus, Ho, Roger, Lim, Yinghao, Kuntjoro, Ivandito, Tay, Edgar, Yip, James, Chew, Nicholas W. S., Low, Ting-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892950/
https://www.ncbi.nlm.nih.gov/pubmed/35252232
http://dx.doi.org/10.3389/fmed.2022.765461
_version_ 1784662283025121280
author Mai, Aaron Shengting
Lim, Oliver Zi Hern
Ho, Yeung Jek
Kong, Gwyneth
Lim, Grace En Hui
Ng, Cheng Han
Ho, Cyrus
Ho, Roger
Lim, Yinghao
Kuntjoro, Ivandito
Tay, Edgar
Yip, James
Chew, Nicholas W. S.
Low, Ting-Ting
author_facet Mai, Aaron Shengting
Lim, Oliver Zi Hern
Ho, Yeung Jek
Kong, Gwyneth
Lim, Grace En Hui
Ng, Cheng Han
Ho, Cyrus
Ho, Roger
Lim, Yinghao
Kuntjoro, Ivandito
Tay, Edgar
Yip, James
Chew, Nicholas W. S.
Low, Ting-Ting
author_sort Mai, Aaron Shengting
collection PubMed
description BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and Embase were searched from inception to 6 May 2021. Meta-analysis of proportions using the generalized linear mixed model was conducted to analyze the pooled prevalence rates of depression and anxiety in PH patients. Risk factors for depression and anxiety in PH patients were evaluated using meta regression. RESULTS: A total of 24 studies involving 2,161 PH patients were included. The pooled prevalence of depression in PH was 28.0% (95% CI: 20.5–36.8) and pooled prevalence of anxiety was 37.1% (95% CI: 28.7–46.4). There was a significantly higher prevalence of anxiety (p = 0.0013) amongst PH patients in Asia (61.1%) compared to Europe (40.3%) and North America (22.9%). In terms of risk factors, congenital heart disease-related pulmonary arterial hypertension (PAH-CHD) were significantly associated with both depression (OR: 1.68, 95% CI: 1.27–2.23, p = 0.024) and anxiety (OR: 1.63, 95% CI: 1.45–1.83, p = 0.002). On the other hand, chronic thromboembolic pulmonary hypertension (CTEPH, OR: 1.18, 95% CI: 1.10–1.26, p = 0.004) was significantly associated with depression, whereas worse pulmonary vascular resistance (β: 0.30, 95% CI: 0.09–0.52, p = 0.005) and cardiac index (β: −0.96, 95% CI: −1.58 to −0.35, p = 0.002) were significantly correlated with anxiety. CONCLUSION: The prevalence of anxiety and depression in PH patients is alarmingly high, with an increased prevalence of anxiety in Asia compared to Europe or North America. Psychological support is warranted for patients with PH, particularly those with underlying congenital heart disease, CTEPH, and severe disease. SYSTEMATIC REVIEW REGISTRATION: CRD42021251733.
format Online
Article
Text
id pubmed-8892950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88929502022-03-04 Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis Mai, Aaron Shengting Lim, Oliver Zi Hern Ho, Yeung Jek Kong, Gwyneth Lim, Grace En Hui Ng, Cheng Han Ho, Cyrus Ho, Roger Lim, Yinghao Kuntjoro, Ivandito Tay, Edgar Yip, James Chew, Nicholas W. S. Low, Ting-Ting Front Med (Lausanne) Medicine BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and Embase were searched from inception to 6 May 2021. Meta-analysis of proportions using the generalized linear mixed model was conducted to analyze the pooled prevalence rates of depression and anxiety in PH patients. Risk factors for depression and anxiety in PH patients were evaluated using meta regression. RESULTS: A total of 24 studies involving 2,161 PH patients were included. The pooled prevalence of depression in PH was 28.0% (95% CI: 20.5–36.8) and pooled prevalence of anxiety was 37.1% (95% CI: 28.7–46.4). There was a significantly higher prevalence of anxiety (p = 0.0013) amongst PH patients in Asia (61.1%) compared to Europe (40.3%) and North America (22.9%). In terms of risk factors, congenital heart disease-related pulmonary arterial hypertension (PAH-CHD) were significantly associated with both depression (OR: 1.68, 95% CI: 1.27–2.23, p = 0.024) and anxiety (OR: 1.63, 95% CI: 1.45–1.83, p = 0.002). On the other hand, chronic thromboembolic pulmonary hypertension (CTEPH, OR: 1.18, 95% CI: 1.10–1.26, p = 0.004) was significantly associated with depression, whereas worse pulmonary vascular resistance (β: 0.30, 95% CI: 0.09–0.52, p = 0.005) and cardiac index (β: −0.96, 95% CI: −1.58 to −0.35, p = 0.002) were significantly correlated with anxiety. CONCLUSION: The prevalence of anxiety and depression in PH patients is alarmingly high, with an increased prevalence of anxiety in Asia compared to Europe or North America. Psychological support is warranted for patients with PH, particularly those with underlying congenital heart disease, CTEPH, and severe disease. SYSTEMATIC REVIEW REGISTRATION: CRD42021251733. Frontiers Media S.A. 2022-02-17 /pmc/articles/PMC8892950/ /pubmed/35252232 http://dx.doi.org/10.3389/fmed.2022.765461 Text en Copyright © 2022 Mai, Lim, Ho, Kong, Lim, Ng, Ho, Ho, Lim, Kuntjoro, Tay, Yip, Chew and Low. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Mai, Aaron Shengting
Lim, Oliver Zi Hern
Ho, Yeung Jek
Kong, Gwyneth
Lim, Grace En Hui
Ng, Cheng Han
Ho, Cyrus
Ho, Roger
Lim, Yinghao
Kuntjoro, Ivandito
Tay, Edgar
Yip, James
Chew, Nicholas W. S.
Low, Ting-Ting
Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title_full Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title_fullStr Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title_full_unstemmed Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title_short Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
title_sort prevalence, risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892950/
https://www.ncbi.nlm.nih.gov/pubmed/35252232
http://dx.doi.org/10.3389/fmed.2022.765461
work_keys_str_mv AT maiaaronshengting prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT limoliverzihern prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT hoyeungjek prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT konggwyneth prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT limgraceenhui prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT ngchenghan prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT hocyrus prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT horoger prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT limyinghao prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT kuntjoroivandito prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT tayedgar prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT yipjames prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT chewnicholasws prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis
AT lowtingting prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis